Abiraterone Acetate Tablet, Film Coated
Product Images NDC 71921-177

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 71921-177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label (Abiraterone Acetate Tablets Usp 500 mg Label)

Bottle Label (Abiraterone Acetate Tablets Usp 500 mg Label)
Label for Abiraterone Acetate 500 mg film-coated tablets, USP. The label shows the product name, strength, and quantity of 60 tablets. It is manufactured for Florida Pharmaceutical Products, LLC, and indicates the product is for prescription use only. Additional storage and usage instructions are included alongside barcodes.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A survival curve chart comparing the percentage survival over time in months for Abiraterone Acetate Tablets versus placebo. The x-axis represents time to death in months, ranging from 0 to 21, and the y-axis shows the percentage survival from 0 to 100%. Two lines depict survival: a solid line for Abiraterone Acetate Tablets and a dashed line for placebo, with patient counts at various time points annotated below the x-axis for both groups.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A survival curve chart depicting the percentage of subjects without death over months from randomization. The x-axis represents time in months, and the y-axis shows the percentage of subjects without death from 0 to 100%. Two curves are shown: one for Abiraterone Acetate Tablets and one for Placebo, with subject numbers at risk listed below the x-axis.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A Kaplan-Meier survival curve chart showing % subjects without radiographic progression or death over months from randomization. Two groups are compared: Abiraterone Acetate Tablets (solid line) and Placebo (dashed line). Time on the X-axis goes from 0 to 18 months, and the Y-axis from 0 to 100%. The graph includes numbers at risk at various time points for each group.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
A Kaplan-Meier survival curve chart showing the percentage of subjects without death over time in months from randomization. Two groups are compared: Abiraterone Acetate and Placebo, with the survival percentage on the vertical axis and months on the horizontal axis. The chart also lists the number of subjects at risk for each group at various time points.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Abiraterone acetate, a steroidal molecule with a pyridine ring and an acetate group. The structure highlights multiple hydrogen atoms attached at various positions in the fused ring system.*
FDA Label Image

F8c59784 D6d5 285c E053 6294a90a4f4b

F8c59784 D6d5 285c E053 6294a90a4f4b
Abiraterone acetate 500 mg film-coated tablet, oral dosage form. The tablet is oval, light brown in color, and imprinted with the letter 'A' on one side. Manufactured by Florida Pharmaceutical Products, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.